週次 |
日期 |
單元主題 |
第2週 |
9/17/2018 |
1. Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges. Curr Oncol Rep (2016) 18: 54 |
第3週 |
9/24/2018 |
中秋節停課 |
第4週 |
10/1/2018 |
2. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: An attempt to understand the sources of variation. Oral Oncol. 2007 Mar;43(3):224-31 |
第5週 |
10/8/2018 |
3. Measuring Depth of Invasion in Early Squamous Cell Carcinoma of the Oral Tongue: Positive Deep Margin, Extratumoral Perineural Invasion, and Other Challenges. Head and Neck Pathology pp 1–8 (2018) https://doi.org/10.1007/s12105-018-0925-3 |
第6週 |
10/15/2018 |
4. WHO is in and WHO is out of the mouth, salivary glands, and jaws sections of the 4th edition of the WHO classification of head and neck tumours. British Journal of Oral and Maxillofacial Surgery 56 (2018) 90–95 |
第7週 |
10/22/2018 |
中華牙醫學會年會停課 |
第8週 |
1029/2018 |
5. Human papillomavirus-related head and neck squamous cell carcinoma variants. Seminars in diagnostic pathology 32 (2015) 23 – 31 |
第9週 |
11/5/2018 |
期中考週停課 |
第10週 |
11/12/2018 |
6. A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus. Head and Neck Pathology (2018) https://doi.org/10.1007/s12105-018-0893-7 |
第11週 |
11/19/2018 |
7. Radiation-induced sarcomas of the head and neck. World J Clin Oncol 2014 December 10; 5(5): 973-981 |
第12週 |
11/26/2018 |
8. An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region. Head and Neck Pathol (2017) 11:364–376 |
第13週 |
12/3/2018 |
9. Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck. Oral Oncology 70 (2017) 34–42 |
第14週 |
12/10/2018 |
10. Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study. J Oral Maxillofac Surg 75:969-977, 2017 |
第15週 |
12/17/2018 |
11. Immunotherapy for Head and Neck Squamous Cell Carcinoma. Current Oncology Reports (2018) 20: 22 |
第16週 |
12/24/2018 |
12. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. 2018 Jan 30. pii: S1044-579X(17)30256-0. doi: 10.1016/j.semcancer.2018.01.008. |
第17週 |
12/31/2018 |
元旦停課 |